We previously reported that the outcome of DSS-induced colitis is reversed by GED 0507-34 Levo (GED, an agonist of PPAR-γ), showing not only anti-inflammatory activity but also higher effectiveness in fibrosis resolution compared to 5-aminosalicylic acid (5-ASA), the gold standard for IBD treatment. Here, PPARG is linked to inflammatory bowel disease.